← FDA Drug Approvals (Drugs@FDA)

SABRIL

NDA · New Drug Application · Sponsor: LUNDBECK PHARMS LLC · Approved 2009-08-21

Drug application

FDA Application #

NDA022006

Application type

New Drug Application

Brand name

SABRIL

Generic name

VIGABATRIN

Active ingredients

VIGABATRIN

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

LUNDBECK PHARMS LLC

Manufacturer

Lundbeck Pharmaceuticals LLC

First approval

2009-08-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown